Related Experiment Video
Updated: Jun 24, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Melanoma gene expression and clinical course
M Vourc'h-Jourdain1, C Volteau, J M Nguyen
1Unit of Skin Cancer Nantes University Hospital, Nantes, France.
Archives of Dermatological Research
|March 28, 2009
Summary
Melanoma gene expression generally shows no link to patient survival. However, MAGE-3 expression in stage III melanoma patients significantly correlates with improved disease-free survival, suggesting specific therapeutic targets.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Melanoma-associated antigens recognized by T cells are targets for immunotherapy.
- Tumor antigen expression heterogeneity can lead to therapeutic escape and disease progression.
Purpose of the Study:
- To investigate the relationship between melanoma gene expression and clinical profiles, particularly patient survival.
- To identify potential tumor escape mechanisms linked to gene expression patterns.
Main Methods:
- Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to analyze gene expression in 202 patient biopsies.
- Evaluated genes included Melan-A, tyrosinase, Na-17A, MAGE-1, MAGE-3, and Ny-ESO-1.
- Gene expression data were correlated with clinical data and patient survival outcomes.
Main Results:
- No overall correlation was found between gene expression and clinical data or survival across all stages.
- Significant interactions were observed between gene expression and disease stage.
- In stage III melanoma, MAGE-3 expression, alone or with other tumor-specific genes, was significantly associated with higher disease-free survival (P = 0.0349; 0.007).
Conclusions:
- Overall, melanoma gene expression did not correlate with clinical data or survival in this cohort.
- Specific tumor gene expression, like MAGE-3 in stage III, may be a significant prognostic indicator for disease-free survival.
- Further research into stage-specific gene expression could refine understanding of melanoma progression and therapeutic strategies.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...